Survodutide vs Tirzepatide: Vanopa Kufananidzwa Sei?

Survodutide ne tirzepatide zvese zvinodhaka zve majekiseni zviri kudzidzirwa pakurasikirwa ne muviri uye hutano hwe metabolic. Musiyano mukuru ndewekuti tirzepatide yakabvumidzwa ne FDA uye inowanikwa zvakanyanya, nepo survodutide ichiri mumiedzo yekiriniki uye isati yavapo kune veruzhinji. Zvinoshandawo kuburikidza nemigwagwa yakasiyana yemahormone, izvo zvinogona kuva zvakakosha kune zvimwe zvido zvehutano.

Kana uri kuyedza kunzwisisa kuti mishonga iyi miviri inofananidzwa sei, heino izvo zviri kutaurwa nekutsvagirwa kusvika parizvino.

Mishonga Yese Inoshanda Sei?

Zvizoro zviviri zviri dual agonists, zvinoreva kuti zvinoshandisa mahormone receptors maviri panguva imwe chete. Asi mapoka erceptori avano tarisa akasiyana, uye izvozvo zvinochinja kuti zvinokanganisa sei muviri wako.

Tirzepatide inotarisa paGLP-1 ne GIP receptors. GLP-1 (glucagon-like peptide-1) inovimbisa kuda kudya, inononoka kudurura dumbu, uye inobatsira kudzora shuga muropa. GIP (glucose dependent insulinotropic polypeptide) inovandudza kuburitswa kwe insulin uye inogona kukanganisa nzira muviri wako unobatwa nayo ne mafuta. Pamwe chete, aya migwagwa miviri inoita zvigadzirwa zvakasimba pakudzora shuga muropa nekurasikirwa ne muviri. Tirzepatide inotengeswa pasi pemazita ekutengesa Mounjaro (ye type 2 diabetes) uye Zepbound (yekuchengetwa kwe muviri).

Survodutide inotarisa paGLP-1 ne glucagon receptors. Inogovana ne GLP-1 activity inovimbisa kuda kudya ne tirzepatide, asi panzvimbo ye GIP, inoshandisa glucagon pathway. Glucagon inobatsira muviri wako kuwedzera kushandiswa kwe simba uye kupisa mafuta akachengetwa, kunyanya mafuta echiropa. Izvi zvinoita kuti survodutide ive inonyanya kufarirwa kune zvirwere zvakadai se MASH (metabolic dysfunction-associated steatohepatitis), fomu rinofambira mberi re chirwere che chiropa che mafuta.

Saka tirzepatide inotarisa pakuda kudya pamwe ne insulin signaling, nepo survodutide inotarisa pakuda kudya pamwe nekupisa simba. Zvese zvinokonzera kurasikirwa ne muviri, asi kuburikidza nemiganhu yakasiyana.

Data Yekurasikirwa Nevhu Inotaura Chii?

Pano ndipo apo vanhu vazhinji vanoda mhinduro yakajeka. Zvichienderana nedatha yemiedzo yekiriniki iripo, tirzepatide parizvino inoratidza zvigadzirwa zvakakura zvekurasikirwa ne muviri kupfuura survodutide.

Chidzidzo chikuru cha2022 chevapinduri 2,539 chakawana kuti tirzepatide pamadosi pakati pe5 ne 15 mg yakagadzira 15 kusvika 20.9 muzana kurasikirwa kwe muviri mushure memavhiki 72. Kunyangwe pamazana makumi mana neshanu, vapinduri vaiona roughly 14 kusvika 19 muzana kurasikirwa kwe muviri. Vamwe vashandisi vemunyika chaiyo vakaona kurasikirwa ne anopfuura 20 muzana ye muviri wavo.

Chidzidzo chesurvodutide che dhipatimende re obesity re dhipatimende rechipiri chakaiswa vanhu 387 uye chakaratidza 6.2 kusvika 14.9 muzana kurasikirwa kwe muviri pamadosi akakwirira mushure memavhiki 46. Mushumo wepamusoro we angasvika 15 muzana kurasikirwa kwe muviri unovimbisa, asi chidzidzo chakanga chiri chipfupi uye chidiki kupfuura zvigadzirwa zvenyeredzi zve tirzepatide.

Zvakakosha kuona kuti survodutide ichiri mumiedzo ye dhipatimende rechitatu. Zvidzidzo zvakakura, zvakare zvicharatidza nhamba dzakasiyana. Asi zvichienderana nezvatinazvo nhasi, tirzepatide inoita kunge inogadzira kurasikirwa kwakakura kwe muviri chose chose.

Ko Kudzora Shuga Muropa Kwakadii?

Tirzepatide ine data yakasimba pano. Miedzo yekiriniki yakaratidza yakaderedza HbA1c (chiyero che shuga ye muropa ypakati pemwedzi mitatu) ne kusvika 2.4 percentage points muvanhu vane type 2 diabetes. Izvi zvimwe zvezvisarudzo zvikuru zvakaonekwa nemishonga ipi ne ipi ye jekiseni ye diabetes.

Survodutide yakaratidzawo kuvandudza kwakaitika muzvikamu zve shuga muropa mu dhipatimende rechipiri re dhipatimende re dhipatimende. Zvisinei, datha iri rakaderera kwazvo uye zvigadzirwa zviri kusimbiswa mumiedzo mikuru.

Kune vanhu vane type 2 diabetes vari kutsvaga sarudzo yakaratidzwa pari zvino, tirzepatide ine hwaro hweuchapupu hwakasimba.

Kupi Kunokunda Survodutide?

Chibatsiro chakasarudzika che survodutide ndicho chiito chayo che glucagon receptor, izvo zvinogona kupa zvibatsiro zvisingave nazvo tirzepatide.

Hutano hweChiropa. Mumiedzo ye dhipatimende rechipiri yevanhu vane MASH yakasimbiswa ne biopsy ne fibrosis ye chiropa, 43 kusvika 62 muzana yevashandisi ve survodutide vakasangana ne chinangwa chikuru che chiropa mushure memavhiki 48, vachienzaniswa ne 14 muzana ne placebo. Pakati pe 34 ne 36 muzana vakaratidzawo zviratidzo zvinopfuura chimwe che fibrosis kuvandudzika. Zvigadzirwa izvi zvakakonzera kufarira kwakakura nekuti MASH parizvino inoshaya mishonga inoshanda kwazvo.

Kushandiswa kwe Simba. Glucagon pathway inogona kuwedzera resting metabolic rate, zvichireva kuti muviri wako unopisa macalories akawanda kunyangwe uri pakuzorora. Iyi inzira yakasiyana ne tirzepatide, iyo inoshanda kunyanya nekuderedza zvakawanda zvaunodya.

Survodutide yakagamuchira FDA Breakthrough Therapy neFast Track designations, izvo zvinoratidza kuti vagadziri vanozviona semushonga unogona kuva wakakosha kune zvirwere zvakakomba. Miedzo yakawanda ye dhipatimende rechitatu mu obesity ne MASH iri kuenderera mberi.

Mishonga Yemamwe Kufananidzwa Sei?

Zvizoro zviviri zvinokonzera zvirwere zve gastrointestinal. Izvi zvakajairika pakati pechirongwa chose che mishonga ye GLP-1.

Nepamwe ne tirzepatide, zvirwere zvinozivikanwa kwazvo zvinosanganisira kuda kurutsa, manyoka, kurutsa, ne kuvimbisa. Mumiedzo yekiriniki, angasvika 4.3 kusvika 7.1 muzana yevapinduri vakarega mushonga nekuda kwezvirwere. Zvizhinji zve GI zvirwere zvakanga zviri zvishoma kusvika zviri pakati nepakati uye zvaiwanzo vandudza nekufamba kwenguva, kunyanya nekuwedzera kwemadosi.

Nepamwe ne survodutide, profile yemashure akafanana: kuda kurutsa, manyoka, kurutsa, ne kuvimbisa. Zvisinei, mumiedzo imwe ye dhipatimende rechipiri ye dhipatimende, zvirwere zve GI zvakaendeswa ne 55 muzana yevashandisi ve survodutide vachienzaniswa ne 22 muzana pa placebo. Maitiro ekuregedza nekuda kwezvirwere anoita kunge akakwirira zvishoma pane tirzepatide's, kunyangwe data reka.

Zvizoro zviviri zvinoda slow dose titration (kutanga pasi uye kuwedzera zvishoma nezvishoma) kubatsira muviri wako kugadzirisa uye kuderedza GI zvirwere.

Ipi Inowanikwa Panguva Ino?

Tirzepatide yakabvumidzwa ne FDA uye inowanikwa ne prescription. Inouya mumapeni e jekiseni akazadzwa kare nemadosi epa vhiki ne vhiki pa 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, ne 15 mg. Inshuwarisi inogona kuivhara pasi pezvimwe zvimiro zve type 2 diabetes kana kuchengetwa kwe muviri.

Survodutide haisati yavumbidzwa kana kuwanikwa kunze kwemiedzo yekiriniki. Hakuna nguva yekuvumbidzwa zvakadaro, sezvo miedzo ye dhipatimende rechitatu ichiri kuenderera mberi. Haugoni kuivawana kuburikidza ne prescription kana pharmacy panguva ino.

Chikuru Chiri Kutaurwa

Tirzepatide yakaratidzwa, sarudzo iripo ne data yakasimba yekurasikirwa ne muviri ne shuga muropa. Survodutide mushonga unokosha uri kutsvagiswa unogona kupa zvibatsiro zvakasarudzika zve chiropa ne metabolic kuburikidza nechiito chayo che glucagon. Kana uchida mushonga zvino, tirzepatide ndiyo sarudzo yakajeka. Kana zvigadzirwa zve dhipatimende rechitatu zve survodutide zvikasimbisa tariro yazvo yekutanga, inogona kuve sarudzo yakakosha munguva pfupi iri kuuya, kunyanya kune vanhu vane chirwere che chiropa che mafuta.